a developer of drugs for the treatment of anemia and vascular diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, AKBA has been loosely correlated with ABOS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if AKBA jumps, then ABOS could also see price increases.
Ticker / NAME | Correlation To AKBA | 1D Price Change % | ||
---|---|---|---|---|
AKBA | 100% | -1.54% | ||
ABOS - AKBA | 43% Loosely correlated | -5.42% | ||
BEAM - AKBA | 41% Loosely correlated | -1.57% | ||
INZY - AKBA | 41% Loosely correlated | -5.59% | ||
ABCL - AKBA | 41% Loosely correlated | -1.35% | ||
KOD - AKBA | 40% Loosely correlated | +8.27% | ||
More |
Ticker / NAME | Correlation To AKBA | 1D Price Change % |
---|---|---|
AKBA | 100% | -1.54% |
drugs theme (254 stocks) | 39% Loosely correlated | -1.72% |
diseases theme (41 stocks) | 37% Loosely correlated | -1.18% |
biotechnology theme (238 stocks) | 32% Poorly correlated | -1.80% |
vascular theme (5 stocks) | 29% Poorly correlated | -1.51% |
Pharmaceuticals theme (308 stocks) | 18% Poorly correlated | -0.54% |